Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.

Invest New Drugs 2009 Oct 8;27(5):393-401. Epub 2008 Oct 8.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.

Pancreatic cancer is a very aggressive malignant disease due to lack of early diagnosis and chemotherapeutic resistance of the tumor cells. There is distinct evidence that food derived polyphenols possess chemopreventive effects in the development of several cancers including pancreatic carcinoma. Resveratrol is one of those phenolic compounds found in grape skins and other fruits with known anticancer activity. Various polymethoxylated resveratrol derivatives showed stronger antiproliferative effects than resveratrol in tumor cell lines. The aim of our study was to evaluate the cytotoxic and biochemical effects of a newly synthesized polymethoxylated resveratrol analogue, N-hydroxy-N'-(3,4,5-trimethoxphenyl)-3,4,5-trimethoxy-benzamidine (KITC) in two human pancreatic cancer cell lines. The human pancreatic cancer cell lines, AsPC-1 and BxPC-3 were used to test the potential inhibitory effect of the resveratrol derivative on cell proliferation and the underlying mechanisms of this effect. After 7 days of incubation, KITC inhibited the growth of AsPC-1 and BxPC-3 cells with IC(50) values of 9.6 and 8.7 microM, respectively. KITC (40 microM) arrested cells in the G0/G1 phase and depleted cells in the S phase of the cell cycle (-105% and -35% of control, respectively). KITC induced dose-dependent apoptosis in both pancreatic cancer cell lines and was found to significantly reduce the in situ activity of ribonucleotide reductase, the key enzyme of DNA synthesis. Employing growth inhibition assays, KITC acted synergistically with gemcitabine in both cell lines. In summary, we found that KITC exerted considerable antitumor activity against human pancreatic cancer cells and could be a promising candidate for further investigations to establish a new chemotherapeutic regimen.

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-008-9183-7
Publisher Site
http://dx.doi.org/10.1007/s10637-008-9183-7DOI Listing
October 2009
16 Reads

Publication Analysis

Top Keywords

cell lines
20
pancreatic cancer
20
human pancreatic
16
cancer cell
12
aspc-1 bxpc-3
12
pancreatic carcinoma
8
resveratrol derivative
8
polymethoxylated resveratrol
8
cell
7
pancreatic
7
kitc
7
resveratrol
6
cells
6
cancer
5
lines
5
bxpc-3 cells
4
underlying mechanisms
4
inhibited growth
4
mechanisms days
4
days incubation
4

References

(Supplied by CrossRef)

AW Blackstock et al.
Oncology (Williston Park) 1996

S Raimondi et al.
Cancer Epidemiol Biomarkers Prev 2007

L Golkar et al.
Surg Res 2007

EP DiMagno et al.
Gastroenterology 1999

SE Norell et al.
Am J Epidemiol 1986

KA Steinmetz et al.
J Am Diet Assoc 1996

L Bravo et al.
Nutr Rev 1998

R Lu et al.
J Cell Physiol 1999

M Jang et al.
Science 1997

Y Schneider et al.
Cancer Lett 2000

M Kampa et al.
Nutr Cancer 2000

Similar Publications